Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exozymes (EXOZ) Share-based Compensation (2023 - 2024)

Exozymes (EXOZ) has disclosed Share-based Compensation for 2 consecutive years, with $317277.0 as the latest value for Q4 2024.

  • Quarterly Share-based Compensation rose 196.25% to $317277.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2024, changed N/A year-over-year, with the annual reading at $2.0 million for FY2025, 76.62% up from the prior year.
  • Share-based Compensation for Q4 2024 was $317277.0 at Exozymes, roughly flat from $317277.0 in the prior quarter.
  • The five-year high for Share-based Compensation was $348275.0 in Q2 2024, with the low at $107098.0 in Q4 2023.